Logan Capital Management Inc. reduced its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 1.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,928 shares of the financial services provider’s stock after selling 497 shares during the period. Logan Capital Management Inc.’s holdings in MetLife were worth $2,551,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in MET. Acadian Asset Management LLC boosted its position in MetLife by 7,837.0% in the 2nd quarter. Acadian Asset Management LLC now owns 1,129,353 shares of the financial services provider’s stock valued at $79,250,000 after buying an additional 1,115,124 shares during the last quarter. Zurich Insurance Group Ltd FI acquired a new position in shares of MetLife in the third quarter worth about $91,771,000. Dimensional Fund Advisors LP grew its stake in MetLife by 22.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider’s stock valued at $378,799,000 after purchasing an additional 988,666 shares in the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its holdings in MetLife by 79.1% during the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,726,209 shares of the financial services provider’s stock worth $142,378,000 after purchasing an additional 762,291 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. raised its position in shares of MetLife by 256.6% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 948,223 shares of the financial services provider’s stock valued at $78,209,000 after purchasing an additional 682,333 shares in the last quarter. 94.99% of the stock is currently owned by hedge funds and other institutional investors.
MetLife Trading Down 0.3 %
MetLife stock opened at $82.99 on Friday. The firm has a 50-day moving average price of $83.77 and a two-hundred day moving average price of $77.33. MetLife, Inc. has a 52-week low of $64.61 and a 52-week high of $89.05. The firm has a market capitalization of $57.46 billion, a price-to-earnings ratio of 16.73, a PEG ratio of 0.74 and a beta of 1.06. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51.
MetLife Announces Dividend
Analyst Ratings Changes
MET has been the subject of a number of recent analyst reports. Barclays decreased their price target on shares of MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a research report on Thursday, October 31st. StockNews.com raised shares of MetLife from a “hold” rating to a “buy” rating in a research report on Monday, November 25th. Piper Sandler lifted their price target on MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd. Morgan Stanley cut their price objective on MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research note on Monday, August 19th. Finally, Wells Fargo & Company lifted their target price on MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Fourteen investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock has an average rating of “Buy” and an average price target of $88.62.
Get Our Latest Research Report on MetLife
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- Stock Splits, Do They Really Impact Investors?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
- Differences Between Momentum Investing and Long Term Investing
- MarketBeat Week in Review – 12/9 – 12/13
- How to Most Effectively Use the MarketBeat Earnings Screener
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.